Close Menu

NEW YORK – MDxHealth reported today that its total revenues for the first half of 2019 dropped 37 percent year over year due to instability in the commercial organization in late 2018 as well as the effects of non-recurring revenue in the year-ago period.

For the six-month period ended June 30, the Belgium-based firm posted total revenues of $10.9 million versus $17.2 million in the same period the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.